Active, not recruitingPhase 2NCT03428802
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Studying Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rutgers, The State University of New Jersey
- Principal Investigator
- Eugenia Girda, MDRutgers Cancer Institute of New Jersey
- Intervention
- Laboratory Biomarker Analysis(other)
- Enrollment
- 21 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2023
Study locations (2)
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03428802 on ClinicalTrials.govOther trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06190834Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.Beijing Tsinghua Chang Gung Hospital
- RECRUITINGNANCT05420064An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsMemorial Sloan Kettering Cancer Center
- RECRUITINGNCT05103969Cohort of Tumors With POLE/D1 MutationFederation Francophone de Cancerologie Digestive
- ENROLLING BY INVITATIONNCT04503213A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell TransplantationMayo Clinic
- RECRUITINGPHASE2NCT03810339Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid TumorsSun Yat-sen University
See all trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia →